ClearVue’s solar glass reaches key commercial milestones

Commercial milestones arrive ahead of a funding test

ClearVue Technologies Limited (ASX:CPV; OTCQX:CVUEF) has built a more credible commercial bridge in the September quarter, signing a binding subcontract for Canva’s Sydney headquarters and clearing key certification hurdles for its solar glazing. The catch is visible in the same filing: ClearVue used A$2.666 million in operating cash during Q1 FY27 and finished with A$2.281 million on hand.

The company calculates total available funding at A$3.381 million, including A$1.1 million of undrawn capacity under its Riverfort facility. On that basis, its estimated funding covers 1.3 quarters at the current operating cash outflow. ClearVue said it expects to continue operating and identified its ATM facility and future capital raising as funding options, but the ATM capacity is contingent on the company activating it and Alpha Investment Partners choosing to exercise its option.

Canva subcontract turns a project pipeline item into production

The Canva development is the clearest commercial step in the quarter. ClearVue signed the binding subcontract with Infinity Constructions Group for integrated solar products at Canva’s headquarters in Surry Hills, converting a Letter of Intent announced in May into a firm commitment. Balustrades, skylights and a rooftop array covering approximately 660 square metres have entered production, with estimated annual generation of about 88,000kWh.

The contract value was not disclosed, so the filing does not yet show how materially the project will affect revenue. It does, however, move the work beyond a proposed project and into manufacturing and installation. That distinction matters for a company whose FY2026 revenue was only A$108,484, as reported in the FY2026 commercialisation test.

Certifications widen the addressable market for solar glass

ClearVue’s Gen 3 Vision Glass received IECEE CB, CE and TÜV MARK certifications from TÜV SÜD after testing against IEC performance and safety standards. The CB certification is recognised in more than 50 markets, while CE certification opens the European Union market. ClearVue also said its design validation testing ran at more than twice the required cycling, although that additional testing is not the same as independently verified commercial sales or long-term field performance.

The company also completed a manufacturing breakthrough for soft solar-control Low-E coatings. The coating was applied to finished photovoltaic glass units at AGC Interpane’s German plant using the same production line and settings as conventional float glass. ClearVue says placing the coating on surface 4, rather than the surface 5 position it says is typically used by other BIPV products, provides greater solar heat-gain reduction. The claim extends the significance of the Low-E coating breakthrough, but commercial uptake remains to be demonstrated.

CEC listing and overseas trials create near-term proof points

ClearVue-Helios rooftop panels have been added to the Clean Energy Council Approved Products List after passing IEC testing and the council’s consumer-protection requirements. The listing allows the panels to be connected to Australia’s grid and makes them eligible for government incentives, following the earlier CEC panel approval. The panels are rated at up to 600W each, with a stated 30-year performance warranty and Class A fire rating.

Meanwhile, Qatar University ordered approximately A$15,000 of transparent photovoltaic glazing for an independent greenhouse trial measuring generation, temperature, light transmission, cooling load and crop productivity. Success could lead to consideration for Qatar’s subsidised food-security greenhouse program, but that outcome is conditional on the trial. In Macau, ClearVue and LandVac have begun the first real-world deployment of their jointly developed insulating PV window at a hotel, with sensors comparing performance against an adjacent room retaining its original single glazing. The first Macau hotel deployment is intended to generate operating data, not yet establish a commercial order book.

Capital raising supports progress but does not remove the funding gap

ClearVue raised A$1.291 million through its share purchase plan, issuing 14.67 million shares at A$0.088 apiece with one three-year option attached to each share. The board accepted applications above the A$1 million target, while the company also repaid A$625,000 of borrowings during the quarter. Net financing cash inflow was A$582,000 after the equity issue, transaction costs and repayment.

That capital has funded a quarter of rapid product and project activity, including the appointment of BIPV specialist Professor Rebecca Yang as an independent non-executive director and ClearVue’s participation in a University of Melbourne ARC research hub backed by A$5 million of government funding. The grant belongs to the hub, not ClearVue. The next test is less about adding another milestone and more about whether production, installation and trial activity can begin converting into cash before another funding decision becomes unavoidable.